Clinical Trials Browser

INDUSTRY × Neuroendocrine Tumors × Doxorubicin × Clear all

NCT01970540 2020-03-09

Study Escalating Doses of PM01183 in Combination With Fixed Doxorubicin in Patients With Specific Advanced Unresectable Solid Tumors

Phase 1 Completed

122 enrolled 19 charts

Neoplasms, Neuroendocrine Tumors